Medicines
Oncology lobby group pushes for PBS pan-tumour subsidies
A new oncology lobby group supported by the pharma industry says that at least 3,500 patients are self-funding non-PBS listed cancer medicines at an average cost of $60,000 annually.
The National Oncology Alliance (NOA) says the figures from a “data on...
A new oncology lobby group supported by the pharma industry says that at least 3,500 patients are self-funding non-PBS listed...
